PARP-inhibitors

BRCA-MUTATED PANCREATIC CANCER. CLINICAL CASES

от

L.A. Akhmetshina1, G.Z. Mukhametshina1,2 , I.S. Tekhteleva2 1Kazan State Medical Academy ― Branch Campus of the FSBEI FPE RMACPE MOH Russia, Kazan 2Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic named after prof. M.Z. Sigal, Kazan Mukhametshina Guzel Z. — Cand. of Sci. (Med.), Associate Professor of the Department of Oncology, radiology … Читать далее

PROSPECTS FOR THE USE OF PARP-INHIBITORS IN ADVANCED GASTRIC CANCER

от

K.V. Menshikov1,2, A.V. Sultanbaev1, R.R. Rakhimov1, A.A. Izmaylov1,2, Sh.I. Musin1, I.A. Menshikova2, R.R. Urazin1, N.I. Sultanbaeva1, A.F. Nasretdinov1, D.O. Lipatov2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa Sultanbaev Aleksandr V. ― Cand. of Sci. (Med.), oncologist, Head of the Department of Anticancer Drug Therapy of Republican Clinical Oncology Dispensary 73/1 Oktyabrya Ave., … Читать далее